IL131803A0 - Method for improving the efficiency of cancer gene therapy - Google Patents
Method for improving the efficiency of cancer gene therapyInfo
- Publication number
- IL131803A0 IL131803A0 IL13180399A IL13180399A IL131803A0 IL 131803 A0 IL131803 A0 IL 131803A0 IL 13180399 A IL13180399 A IL 13180399A IL 13180399 A IL13180399 A IL 13180399A IL 131803 A0 IL131803 A0 IL 131803A0
- Authority
- IL
- Israel
- Prior art keywords
- improving
- efficiency
- gene therapy
- cancer gene
- cancer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL13180399A IL131803A0 (en) | 1999-09-08 | 1999-09-08 | Method for improving the efficiency of cancer gene therapy |
| AU70369/00A AU7036900A (en) | 1999-09-08 | 2000-09-08 | Method of gene therapy for improving the efficiency of cancer therapy |
| PCT/IL2000/000546 WO2001018056A2 (en) | 1999-09-08 | 2000-09-08 | Method of gene therapy for improving the efficiency of cancer therapy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL13180399A IL131803A0 (en) | 1999-09-08 | 1999-09-08 | Method for improving the efficiency of cancer gene therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL131803A0 true IL131803A0 (en) | 2001-03-19 |
Family
ID=11073227
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13180399A IL131803A0 (en) | 1999-09-08 | 1999-09-08 | Method for improving the efficiency of cancer gene therapy |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU7036900A (en) |
| IL (1) | IL131803A0 (en) |
| WO (1) | WO2001018056A2 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2295315A1 (en) * | 1997-06-26 | 1999-01-07 | The University Of North Carolina At Chapel Hill | Targeted gene transfer using g protein coupled receptors |
| ES2342239T3 (en) * | 1998-08-25 | 2010-07-02 | Merck Patent Gmbh | EXPRESSION AND EXPORT OF ANGIOSTATIN AND ENDOSTATINE AS IMMUNOFUSINS. |
-
1999
- 1999-09-08 IL IL13180399A patent/IL131803A0/en unknown
-
2000
- 2000-09-08 WO PCT/IL2000/000546 patent/WO2001018056A2/en not_active Ceased
- 2000-09-08 AU AU70369/00A patent/AU7036900A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001018056A2 (en) | 2001-03-15 |
| AU7036900A (en) | 2001-04-10 |
| WO2001018056A3 (en) | 2001-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001294604A1 (en) | Improved radiation therapy treatment method | |
| EP1146912A4 (en) | Method for improved radiation therapy | |
| IL159461A0 (en) | Method for enhancing the effectiveness of cancer therapies | |
| HUP0402656A3 (en) | A cell therapy method for the treatment of tumors | |
| AU2879300A (en) | Methods for anti-tumor therapy | |
| SI1176964T1 (en) | Uses of et743 for treating cancer | |
| IL148579A0 (en) | Oncolytic combinations for the treatment of cancer | |
| HUP0103252A3 (en) | Gene therapy method | |
| MXPA03007036A (en) | Method of cancer therapy. | |
| GB2389532B (en) | The method of treating cancer | |
| AU7363000A (en) | Method for reducing the risk of cancer | |
| GB0025890D0 (en) | Gene therapy | |
| ZA200203166B (en) | Treatment of cancer. | |
| IL131803A0 (en) | Method for improving the efficiency of cancer gene therapy | |
| GB9900009D0 (en) | Gene therapy | |
| AU5778399A (en) | Gene therapy for treatment of cancer | |
| GB0406539D0 (en) | Gene therapy | |
| EP1225222A4 (en) | Novel tumor suppressor gene | |
| AU2616201A (en) | Cancer treatment method | |
| AU4552700A (en) | Gene therapy | |
| AU1592901A (en) | Oncolytic combinations for the treatment of cancer | |
| GB9910587D0 (en) | Gene therapy | |
| GB9920837D0 (en) | Gene therapy | |
| GB9811836D0 (en) | Gene therapy method | |
| GB9814989D0 (en) | Gene therapy method |